Synthekine
Discovering, Developing and Commercializing the Next Generation of Selective Cytokine Therapeutics. We believe that cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm of cancer and inflammatory disease.
Basic Information
- Category: business
- Website: https://www.synthekine.com
Documented Facts
- Inception (Wikidata): 2020 (Source 2: Wikidata Q117405665, revision 2474496175)
- Country (Wikidata; date unspecified): United States (Source 2: Wikidata Q117405665, revision 2474496175; Source 3: Wikidata label: Q30, revision 2556188301)
- Official website (Wikidata; date unspecified): https://www.synthekine.com/ (Source 2: Wikidata Q117405665, revision 2474496175)
Evidence and Sources
- Synthekine — Official Site (official)
- Wikidata Q117405665, revision 2474496175 (knowledge-base)
- Wikidata label: Q30, revision 2556188301 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Synthekine.
- Canonical profile: https://brandsource.ai/brands/synthekine
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/synthekine/json-ld
- Citation profile API: https://brandsource.ai/api/brands/synthekine/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Discovering, Developing and Commercializing the Next Generation of Selective Cytokine Therapeutics. We believe that cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm of cancer and inflammatory disease.
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.